The purported health benefits now appear to be even more far-reaching, with the latest data from a trial called Select, published in 2023, showing that semaglutide can slash the risk of heart attacks and strokes by a fifth in patients with an existing history of cardiovascular disease
We focus on the pharmacokinetic and pharmacodynamic properties of the recently approved oral GLP-1 receptor agonist, oral semaglutide
Their effects depend on the individual, their baseline digestive health, and their underlying risk factors
Your Diagnosis Coverage may depend on whether the prescription is associated with type 2 diabetes, obesity, another health condition or an excluded use
Meanwhile, the antioxidant-rich Green Tea Extract further amplifies fat oxidation, boosts metabolic rate, and supports cardiovascular and immune health